ArticleClinical and experimental nephrology2019
Correction to: Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan.
Tetsuhiro Tanaka et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.